PDS Biotechnology Corp (PDSB) stock
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.89−0.03 (-3.28%)
Close on Nov 17, 2026Market cap $50.03MP/E –Yield –
PDS Biotechnology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2020 it was -$14.89M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$14.89M | – |
| FY2019 | Dec 31, 2019 | -$21.03M | – |
| FY2018 | Dec 31, 2018 | -$3.58M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -$4.03M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.92M | – |
See a number that looks wrong?